Adamas to Present at Upcoming Piper Sandler Conference
Adamas Pharmaceuticals (Nasdaq: ADMS) has announced that CEO Neil F. McFarlane will participate in a fireside chat at the Piper Sandler 32nd Annual Virtual Healthcare Conference from December 1-3, 2020. This event aims to discuss the company's commitment to developing innovative medicines for neurological diseases.
The pre-recorded chat will be available for replay starting November 23, 2020, for 30 days, accessible on the Adamas investor relations website.
- None.
- None.
EMERYVILLE, Calif., Nov. 18, 2020 (GLOBE NEWSWIRE) -- Adamas Pharmaceuticals, Inc. (Nasdaq: ADMS), a company dedicated to developing and delivering medicines that make a meaningful difference to people affected by neurological diseases, today announced that Neil F. McFarlane, the Company’s Chief Executive Officer, will participate in a fireside chat at the Piper Sandler 32nd Annual Virtual Healthcare Conference being held December 1-3, 2020.
A replay of the pre-recorded fireside chat will be available beginning November 23, 2020 in the investor relations section of the Adamas website at http://ir.adamaspharma.com/events-presentations. The replay will be available for 30 days.
About Adamas Pharmaceuticals, Inc.
At Adamas our vision is clear – to deliver innovative medicines that reduce the burden of neurological diseases on patients, caregivers and society. We are a fully integrated company focused on growing a portfolio of therapies to address a range of neurological diseases. For more information, please visit www.adamaspharma.com.
Contact
| Media: Sarah Mathieson Vice President, Corporate Communications 510-450-3528 smathieson@adamaspharma.com | Investors: Peter Vozzo Managing Director, Westwicke 443-213-0505 peter.vozzo@westwicke.com |
FAQ
When will Neil F. McFarlane speak at the Piper Sandler Healthcare Conference?
Where can I find the replay of the fireside chat with Adamas Pharmaceuticals' CEO?
What is the focus of Adamas Pharmaceuticals?
How long will the replay of the fireside chat be available?
What is the stock symbol for Adamas Pharmaceuticals?
